CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma MicroenvironmentTomohiro Fujiwara, John H. Healey, Mohamed A. Yakoub et al.|Molecular Cancer Therapeutics|2021Cited by 258
Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcomaTomohiro Fujiwara, Toshifumi Ozaki, Koji Uotani et al.|Oncotarget|2017Cited by 118
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effectsTakenori Uehara, Heiichiro Udono, Toshifumi Ozaki et al.|International Immunology|2018Cited by 118
Clinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating CellsTomohiro Fujiwara, Takahiro Ochiya, Takeshi Katsuda et al.|Stem Cells|2013Cited by 72
Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi‐institutional studyKoichi Ogura, Akira Kawai, Tomohiro Fujiwara et al.|Cancer|2015Cited by 71